Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NS5A inhibitors(Nonstructural protein 5A inhibitors), RdRp inhibitors(RNA-directed RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Phase 2 | BE | 09 Feb 2020 |